webinar register page

BiondVax Webinar
CEO Amir Reichman will discuss recent business updates including:

The nanosized antibody (NanoAb) pipeline development collaboration with the Max Planck Institute for Multidisciplinary Sciences (MPG) and University Medical Center Göttingen (UMG), Germany

In-house preparations for the manufacturing of NanoAbs at the Company's GMP biologics manufacturing facility in Jerusalem

Negotiations regarding restructuring of the European Investment Bank's loan providing continued long-term support for BiondVax.

FY'21 financial results

The webinar will also feature Professor Dr. Matthias Dobbelstein, a Fellow at MPG and Professor at UMG, who will briefly discuss the recent NanoAb research results. Time permitting, the webinar will be opened to questions and answers.


* Required information